Schmäche, Tim
Fohgrub, Juliane
Klimova, Anna
Laaber, Karin
Drukewitz, Stephan
Merboth, Felix
Hennig, Alexander
Seidlitz, Therese
Herbst, Friederike
Baenke, Franziska
Ada, Anne-Marlen
Groß, Thomas
Wenzel, Carina
Ball, Claudia R.
Praetorius, Christian
Schmidt, Thomas
Ringelband-Schilling, Barbara
Koschny, Ronald
Stenzinger, Albrecht
Roeder, Ingo
Jaeger, Dirk
Zeissig, Sebastian
Welsch, Thilo
Aust, Daniela
Glimm, Hanno
Folprecht, Gunnar
Weitz, Jürgen
Haag, Georg M.
Stange, Daniel E.
Article History
Received: 17 November 2023
Accepted: 19 December 2023
First Online: 10 January 2024
Declarations
:
: This study was conducted according to the principles of the Declaration of Helsinki. Human material was collected after providing informed consent within the OPPOSITE trial (ClinicalTrials.gov #NCT03429816) approved by the ethics committee of the TU Dresden (EK 169052018) and University Heidelberg (S-686/2017).
: Albrecht StenzingerConsulting or Advisory role: Aignostics, Amgen, Astra Zeneca, Bayer, BMS, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, Roche, Seattle Genetics, Takeda, Thermo Fisher.Research Funding: Bayer, BMS, Chugai, Incyte.Dirk JaegerConsulting or Advisory role: Amgen, BMS, Cure Vac, Definierens, F. Hoffmann-La Roche, Genmab A-S, Life Science Inkubator and Vaxxim, Zelluna, OncoOne Research Development.Gunnar FolprechtResearch Funding: Merck.Honoraria, Consulting or Advisory Role: Merck, Roche, Amgen, Lilly, Sanofi-Aventis, Servier, Bayer, BMS and MSD.Georg M. HaagConsulting or Advisory role: Bristol-Myers Squibb, MSD Sharp & Dohme, Lilly, Novartis; Daiichi Sankyo; Servier; MSD Sharp & Dohme.Research Funding: Nordic Pharma, Taiho Pharmaceutical, MSD Sharp & Dohme.Travel, Accommodations, Expenses: Bristol-Myers Squibb, Lilly, Servier and MSD Sharp & Dohme.Karin LaaberCurrent Employment: Merck KGaA.Ronald KoschnyHonorary Lectures: Abbvie, Sanofi-Aventis, Bristol-Myers Squibb, Bayer Vital, Norgine.Daniel E. StangeResearch Funding: Ardeypharm.No disclosures were reported by the other authors.